For our list of the worst Ark stocks to buy according to short sellers, we ranked the 110 largest holdings in Ark Invest’s Q3 ...

Recursion on Tuesday held a webinar to discuss results from the Phase 1/2 study of REC-617, a selective CDK7 inhibitor, in advanced solid tumors. The results were presented at an AACR Special ...

Roche (RHHBY) announced that it has commenced a tender offer for all of the outstanding shares of common stock of Poseida Therapeutics, Inc.

Recursion expects to meet with FDA to discuss the potential of advancing REC-994 for treatment of patients with cerebral ...

In premarket trading, as of 6:50 a.m. EDT, the stock jumped 35.13% to $0.50, although it is down about 91% for the year. Some ...

The artificial intelligence (AI) revolution extends far beyond chatbots and automation to fundamentally restructure ...

(NASDAQ:RXRX – Free Report) by 17.5% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & ...

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its stake in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Free Report) by 2.1% during the third quarter, according to ...

Recursion Pharmaceuticals Inc (RXRX) stock saw a decline, ending the day at $6.59 which represents a decrease of $-0.54 or -7.57% from the prior close of $7.13. The stock opened at $7.12 and touched a ...

Palo Alto Networks Inc (NASDAQ:PANW) stock is on track for a record close and fifth-straight win today. The equity sports a ...

We recently compiled a list of the Jim Cramer’s Lightning Round: 7 Stocks to Watch. In this article, we are going to take a ...